Why the study?
The optimal management of pheochromocytoma-induced cardiomyopathy, particularly for severe cases presenting with refractory cardiogenic shock requiring mechanical circulatory support, remains unclear.
Early resection of pheochromocytoma under VA-ECMO support following accelerated alpha blockade is a feasible and potentially life-saving strategy for patients with refractory cardiogenic shock due to pheochromocytoma-induced cardiomyopathy.
Alerts clinicians to pheochromocytoma cardiomyopathy in unexplained refractory post-operative shock; leaves open optimal mechanical support strategies.
Background: Pheochromocytoma-induced cardiomyopathy is a rare but potentially life-threatening complication of pheochromocytoma. It mimics the patterns of stress-induced cardiomyopathy. In severe cases, patients can develop refractory cardiogenic shock, which might require mechanical circulatory support. Case Presentation: We presented a case of 54-year-old female who developed refractory cardiogenic shock, following an elective orthopaedic surgery complicated by cardiac arrest, requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support. After urgent coronary catheterisation revealed normal coronary arteries, further evaluation of the aetiology of cardiogenic shock revealed pheochromocytoma. With a diagnosis of pheochromocytoma-induced cardiomyopathy, the patient had accelerated preoperative alpha adrenergic blockade preparation for a total of 6 days and subsequently had the tumour removed under VA-ECMO support. Postoperatively, the patient recovered well and was off ECMO support and extubated a few days later.The optimal management of pheochromocytoma-induced cardiomyopathy, especially for severe cases, is still unclear. Indeed, some cases will require mechanical circulatory support to allow left ventricular function recovery. But our case also showed that it was possible to introduce alpha blockade safely whilst the patient is on VA-ECMO and has the pheochromocytoma removed with VA-ECMO support after accelerated preoperative preparation.
No takes yet. Share an insight, caveat, or question.
Lyu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: